Your browser doesn't support javascript.
Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity.
Das, Santa Kumar; Ranabhat, Kamal; Bhattarai, Suraj; Karki, Khem Bahadur; Gyanwali, Pradip; Paneru, Hem Raj; Nepal, Bipin; Dumre, Shyam Prakash; Acharya, Subhash Prasad.
  • Das SK; Institute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
  • Ranabhat K; Institute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
  • Bhattarai S; Ministry of Health and Population Kathmandu Nepal.
  • Karki KB; Global Institute for Interdisciplinary Studies Kathmandu Nepal.
  • Gyanwali P; Institute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
  • Paneru HR; Institute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
  • Nepal B; Institute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
  • Dumre SP; Grande International Hospital Kathmandu Nepal.
  • Acharya SP; Central Department of Microbiology Tribhuvan University Kathmandu Nepal.
Clin Case Rep ; 9(4): 2132-2137, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1095251
ABSTRACT
Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID-19 patients with obesity and chronic diseases such as diabetes and hypertension.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Clin Case Rep Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Clin Case Rep Year: 2021 Document Type: Article